StonvexLoading…
StonvexStonvexStonvexCore line items from GNE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $101.64M | $142.31M | $501.97M | $138.32M | $105.52M |
Operating Income | Not available | $1.87M | $27.72M | $21.77M | $14.83M |
Net Income | Not available | $2.78M | $24.01M | $20.20M | $13.45M |
EPS (Diluted) | $0.27 | $0.11 | $0.90 | $0.25 | $0.09 |
Total Assets | Not available | $376.46M | $389.38M | $394.12M | $383.09M |
Total Liabilities | Not available | $131.15M | $144.93M | $205.30M | $195.93M |
Cash & Equivalents | Not available | $185.88M | $203.52M | $109.28M | $105.42M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 26.14M | 26.54M | 26.55M | 26.63M |